Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Brain Neoplasms 4Neoplasms 3Prostatic Neoplasms 2Urogenital Neoplasms 1Radiation Pneumonitis 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Optic Neuritis 1Neoplasm, Residual 1Neoplasm Metastasis 1Myelitis, Transverse 1Myelitis 1Myasthenia Gravis 1Lung Neoplasms 1Lung Diseases, Interstitial 1Leukemia, Hairy Cell 1Hematologic Neoplasms 1Graft vs Host Disease 1Glioma 1Genital Neoplasms, Male 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Tomography, Emission-Computed, Single-Photon 1Respiratory Function Tests 1Radiotherapy 1Dexamethasone 1Adrenal Cortex Hormones 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Pneumonitis × Adrenal Cortex Hormones × 1 year × Clear all
NCT05986318 2026-03-09

RESPIRE-ILD

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Recruiting
98 enrolled
Thoracic

Lung Neoplasms, Lung Diseases, Interstitial, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡